A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Status:
Active, not recruiting
Trial end date:
2022-03-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of treatment with guselkumab in
participants with familial adenomatous polyposis (FAP) on rectal/pouch polyp burden.